KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Interest Expenses: 2010-2025

Historic Interest Expenses for Emergent BioSolutions (EBS) over the last 13 years, with Sep 2025 value amounting to $15.2 million.

  • Emergent BioSolutions' Interest Expenses rose 83.13% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.4 million, marking a year-over-year decrease of 23.75%. This contributed to the annual value of $71.0 million for FY2024, which is 19.23% down from last year.
  • Per Emergent BioSolutions' latest filing, its Interest Expenses stood at $15.2 million for Q3 2025, which was up 3.40% from $14.7 million recorded in Q2 2025.
  • Emergent BioSolutions' Interest Expenses' 5-year high stood at $28.6 million during Q2 2023, with a 5-year trough of $7.8 million in Q2 2022.
  • For the 3-year period, Emergent BioSolutions' Interest Expenses averaged around $18.5 million, with its median value being $17.9 million (2023).
  • Per our database at Business Quant, Emergent BioSolutions' Interest Expenses soared by 266.67% in 2023 and then crashed by 57.87% in 2024.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Interest Expenses stood at $9.0 million in 2021, then skyrocketed by 42.22% to $12.8 million in 2022, then surged by 69.53% to $21.7 million in 2023, then tumbled by 31.80% to $14.8 million in 2024, then spiked by 83.13% to $15.2 million in 2025.
  • Its last three reported values are $15.2 million in Q3 2025, $14.7 million for Q2 2025, and $14.7 million during Q1 2025.